...
机译:Cost-Effectiveness of Mirabegron Compared with Antimuscarinic Agents for the Treatment of Adults Overactive Bladder in the United Kingdom
Astellas Pharma Global Dev, Leiden, Netherlands;
Astellas Pharma Europe Ltd, Chertsey KT16 0RS, Surrey, England;
Creat Ceut SARL, Paris, FranceCreat Ceut Ltd, London, England;
antimuscarinic drugs; cost-effectiveness analysis; mirabegron; overactive bladder;